Home > Annual Financials > ADVANCED ENZYME TECHNOLOGIES

ADVANCED ENZYME TECHNOLOGIES Financial Statement Analysis
[BOM: 540025|NSE : ADVENZYMES]

The Revenues of ADVANCED ENZYME TECHNOLOGIES have increased by 17.09% YoY .
The Earnings Per Share (EPS) of ADVANCED ENZYME TECHNOLOGIES has increased by 28.58 % YoY.
COMMUNITY POLL
for ADVANCED ENZYME TECHNOLOGIES
Please provide your vote to see the results

ADVANCED ENZYME TECHNOLOGIES Last 5 Annual Financial Results
[BOM: 540025|NSE : ADVENZYMES]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹746 Cr₹637 Cr₹624 Cr₹541 Cr₹529 Cr
Expenses ₹516 Cr₹441 Cr₹419 Cr₹383 Cr₹327 Cr
Operating Profit (Excl OI) ₹229 Cr₹196 Cr₹205 Cr₹158 Cr₹203 Cr
Other Income ₹36 Cr₹33 Cr₹37 Cr₹25 Cr₹6.42 Cr
Interest ₹3.73 Cr₹4.63 Cr₹4.12 Cr₹3.48 Cr₹2.96 Cr
Depreciation ₹40 Cr₹37 Cr₹35 Cr₹35 Cr₹35 Cr
Profit Before Tax ₹233 Cr₹187 Cr₹188 Cr₹140 Cr₹171 Cr
Profit After Tax ₹174 Cr₹134 Cr₹137 Cr₹104 Cr₹124 Cr
Consolidated Net Profit ₹169 Cr₹131 Cr₹133 Cr₹106 Cr₹120 Cr
Earnings Per Share (Rs)₹15.07₹11.72₹11.92₹9.45₹10.70
PAT Margin (%)23.2421.0321.9219.1823.34
ROE(%)11.439.7910.728.9412.04
ROCE(%)15.2713.7614.7812.2616.66
Total Debt/Equity(x)0.010.020.020.010.01

Key Financials

Market Cap : ₹ 3,405.9 Cr
Revenue (TTM) : ₹ 749.6 Cr
Net Profit(TTM) : ₹ 171.8 Cr
EPS (TTM) : ₹ 15.3
P/E (TTM) : 19.8

Industry Peers & Returns1W1M1Y
ADVANCED ENZYME TECHNOLOGIES 3.3% -6.4% -3.6%
SUN PHARMACEUTICAL INDUSTRIES -1.4% -1.3% 21.5%
DIVIS LABORATORIES 2.7% 16.1% 38.6%
TORRENT PHARMACEUTICALS -1.5% -3.3% 35.6%
CIPLA -0.7% 1.4% -2%
DR REDDYS LABORATORIES 3.9% -1.8% 0.4%
MANKIND PHARMA -0.7% -4.9% -4.9%
LUPIN -1.8% -10.6% 16.2%
ZYDUS LIFESCIENCES 1.7% -1.2% 24.1%


ADVANCED ENZYME TECHNOLOGIES Revenues
[BOM: 540025|NSE : ADVENZYMES]

Y-o-Y

17.09 %

5 Yr CAGR

8.94 %

Years Revenues % Change
Mar2026 ₹746 Cr
17.09
Mar2025 ₹637 Cr
2.09
Mar2024 ₹624 Cr
15.39
Mar2023 ₹541 Cr
2.13
Mar2022 ₹529 Cr -


ADVANCED ENZYME TECHNOLOGIES Operating Profit
[BOM: 540025|NSE : ADVENZYMES]

Y-o-Y

17.26 %

5 Yr CAGR

3.14 %

Years Operating Profit % Change
Mar2026 ₹229 Cr
17.26
Mar2025 ₹196 Cr
-4.79
Mar2024 ₹205 Cr
30.38
Mar2023 ₹158 Cr
-22.25
Mar2022 ₹203 Cr -

Operating Margins
Y-o-Y

0.13 %

5 Yr CAGR

-5.33 %

Years Operating Margin% % Change
Mar2026 30.74%
0.13
Mar2025 30.7%
-6.72
Mar2024 32.91%
12.98
Mar2023 29.13%
-23.88
Mar2022 38.27% -

ADVANCED ENZYME TECHNOLOGIES Profit After Tax
[BOM: 540025|NSE : ADVENZYMES]

Y-o-Y

28.68 %

5 Yr CAGR

8.99 %

Years Profit After Tax % Change
Mar2026 ₹169 Cr
28.68
Mar2025 ₹131 Cr
-1.64
Mar2024 ₹133 Cr
26.19
Mar2023 ₹106 Cr
-11.66
Mar2022 ₹120 Cr -

PAT Margins
Y-o-Y

10.51 %

5 Yr CAGR

-0.11 %

Years PAT Margin(%) % Change
Mar2026 23.24 %
10.51
Mar2025 21.03 %
-4.06
Mar2024 21.92 %
14.29
Mar2023 19.18 %
-17.82
Mar2022 23.34 % -

ADVANCED ENZYME TECHNOLOGIES Earnings Per Share (EPS)
[BOM: 540025|NSE : ADVENZYMES]

Y-o-Y

28.58 %

5 Yr CAGR

8.94 %

Years EPS % Change
Mar2026 ₹15
28.58
Mar2025 ₹12
-1.68
Mar2024 ₹12
26.14
Mar2023 ₹9.45
-11.68
Mar2022 ₹11 -

ADVANCED ENZYME TECHNOLOGIES Return on Capital Employed (ROCE)
[BOM: 540025|NSE : ADVENZYMES]

Y-o-Y

10.97 %

5 Yr CAGR

-2.15 %

Years ROCE % Change
Mar2026 15.27%
10.97
Mar2025 13.76%
-6.90
Mar2024 14.78%
20.55
Mar2023 12.26%
-26.41
Mar2022 16.66% -

ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex

Current Share Price : ₹304.1
Current MarketCap: ₹ 3,405.9 Cr
Updated EOD on :Aug 14,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
ADVANCED ENZYME TECHNOLOGIES

3.3%

-6.4%

-3.6%

SENSEX

-0.6%

1.1%

-3.2%

ADVANCED ENZYME TECHNOLOGIES related INDICES

BSE Indices1W1M1Y
BSE 1000 -0.3% 1.7% 4.4%
BSE HEALTHCARE -0.5% 1% 17.4%
NSE Indices1W1M1Y
NIFTY MICROCAP 250 0.4% 2.8% 12%
NIFTY SMALLCAP 500 -0.2% 1.6% NA
NIFTY TOTAL MARKET -0.5% 1.5% 4.4%

You may also like the below Video Courses


FAQ about ADVANCED ENZYME TECHNOLOGIES Financials


How the annual revenues of ADVANCED ENZYME TECHNOLOGIES have changed ?

The Revenues of ADVANCED ENZYME TECHNOLOGIES have increased by 17.09% YoY .

How the Earnings per Share (EPS) of ADVANCED ENZYME TECHNOLOGIES have changed?

The Earnings Per Share (EPS) of ADVANCED ENZYME TECHNOLOGIES has increased by 28.58 % YoY .